A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
Proglumide has been studied across 20 research domains including 🔬 Oncology, 💊 Pain, 🦠 Gut & Microbiome, 🧬 Hormones, 🌤️ Mood & Depression. The primary research focus is 🔬 Oncology with 13% of studies addressing this area.
This evidence profile for Proglumide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.